Skip to main content
. 2019 Dec 29;176(24):4666–4680. doi: 10.1111/bph.14831

Figure 8.

Figure 8

Schematic diagram of the antifibrotic effect of praziquantel in inhibition of hepatic stellate cells activation. Praziquantel increased the expression of Smad7 that inhibited Smad2/3 phosphorylation to inhibit the TGF‐β/Smad signalling. This can further result in the inhibition of HSCs activation and extracellular matrix (ECM) production